New Research Poster Presentation 2.49: Similar Efficacy Results in Short-Term and Long-Term Studies of Adult and Adolescent Patients with Schizophrenia Treated with Aripiprazole

Thursday, October 29, 2009 8:30 AM

Margaretta Nyilas, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Christoph U. Correll, M.D., Psychiatry, The Zucker Hillside Hospital/Albert Einstein College of Medicine, Glen Oaks, NY

Catherine Aurang, B.A., Global Clinical Development, Otsuka America Pharmaceutical, Inc., Princeton, NJ

Na Jin, M.S., Biostatistics, Otsuka America Pharmaceutical, Inc., Rockville, MD

Taro Iwamoto, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Randall Owen, M.D., Bristol-Myers Squibb Comopany, Wallingford, CT

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

William Carson, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Robert A. Forbes, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 2.49 Similar Efficacy Results in Short-Term and Long-Term Studies of Adult and Adolescent Patients with Schizophrenia Treated with Aripiprazole